Giles Day, CEO

Giles graduated from the University of Manchester with BSc in Biology and MSc in Bioinformatics. From there he joined Pfizer in the UK establishing Bioinformatics as a core discipline within the drug discovery programs. Over the next 15 years Giles held numerous leadership postions in the Pfizer informatics organization. His teams developed ground-breaking solutions for HTS, med chem and target identification. In 2007 Pfizer created a new R&D division, the Biotechnology and Bioinnovation Center (BBC) in San Francisco. Giles was appointed head of informatics for the division leading a global team that supported all aspects of the BBC, from Prof. Goodmans Blackberry to running protein-protein docking at Amazon and supporting clinical trials. Following the Wyeth merger and disbanding of the BBC, Giles, Jake and Chris decided that this was the ideal time to create Distributed Bio and bring their wealth of experience to new partners. Chris and Giles formed Distributed Bio LLC in 2011, and incorporated to Distributed Bio Inc with Chris, Giles and Jake in 2012.